Valnoctamide
SIGMA/V4765 - ≥98% (NMR)
Synonym: 2-
CAS Number: 4171-13-5
Empirical Formula (Hill Notation): C8H17NO
Molecular Weight: 143.23
MDL Number: MFCD00868184
Linear Formula: C8H17NO
Product Type: Chemical
| assay | ≥98% (NMR) |
| color | white to off-white |
| form | powder |
| InChI | 1S/C8H17NO/c1-4-6(3)7(5-2 |
| InChI key | QRCJOCOSPZMDJY-UHFFFAOYSA |
| Quality Level | 100  |
| SMILES string | CCC(C)C(CC)C(N)=O |
| solubility | DMSO: 20 mg/mL, clear |
| storage condition | desiccated |
| storage temp. | room temp |
| Application: | Valnoctamide has been used: • as a mood stabilizer to study its anti-cytomegalovirus (anti-CMV) effects in newborn mice brain • as a hypnotic sedative to study its cytotoxic effects on oligodendrocyte precursor cells (OPCs) and human oligodendroglioma cell line (HOG) • as a mood stabilizer to study its effects on inhibition of human cytomegalovirus |
| Biochem/physiol Actions: | Valnoctamide exhibits anti-cytomegalovirus (ant |
| Biochem/physiol Actions: | Valproic acid (VPA) and derivatives such as valpromide and valnoctamide are anti-convulsant, mood stabilizing drugs, believed to function as indirect GABA agonists by inhibiting the transamination of GABA. |
| Features and Benefits: | This compound is featured on the Glutamate/GABA Synthesis and Metabolism page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (NMR) |
| Storage Temp. | room temp |
| UNSPSC | 12352200 |